The eye: A window to the soul of the immune system

Journal of Autoimmunity

Volumn 45, Issue , 2013, Pages 7-14

  Perez, V L ^a,b   Saeed, A M ^a   Tan, Y ^a   Urbieta, M ^a   Cruz Guilloty, F ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Allo transplantation; Cornea; Inflammation; Oxidative stress; Retina

Indexed keywords

ACUTE DISEASE; ADAPTIVE IMMUNITY; ANTERIOR EYE SEGMENT; ARTICLE; AUTOIMMUNITY; BLOOD RETINA BARRIER; CHRONIC INFLAMMATION; CORNEA TRANSPLANTATION; EYE; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; INNATE IMMUNITY; MACROPHAGE; NEUTROPHIL; NONHUMAN; PIGMENT EPITHELIUM; POSTERIOR EYE SEGMENT; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ALLO-TRANSPLANTATION; CORNEA; INFLAMMATION; OXIDATIVE STRESS; RETINA;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNE DISEASES; CORNEAL TRANSPLANTATION; EYE; EYE DISEASES; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; MACULAR DEGENERATION; MONITORING, IMMUNOLOGIC; T-LYMPHOCYTES;

EID: 84884279693     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2013.06.011     Document Type: Article

References (67)

1. van Dooremaal J.C. Die Entwicklung der in fremden Grund versetzten lebenden Geweba. Albrecht Von Graefes Arch Ophthalmol 1873, 19:358.
2. Medawar P.B. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 1948, 29:58-69.
3. Streilein J.W. Anterior chamber associated immune deviation: the privilege of immunity in the eye. Surv Ophthalmol 1990, 35:67-73.
4. Streilein J.W. Immune regulation and the eye: a dangerous compromise. FASEB J 1987, 1:199-208.
5. Kaplan H.J., Streilein J.W. Immune response to immunization via the anterior chamber of the eye. I. F. lymphocyte-induced immune deviation. JImmunol 1977, 118:809-814.
6. Stein-Streilein J., Streilein J.W. Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy. Int Rev Immunol 2002, 21:123-152.
7. Anonymous Report of the organ transplant panel. Corneal transplantation. Council on Scientific Affairs. JAm Med Assoc 1988, 259:719-722.
8. Maguire M.G., Stark W.J., Gottsch J.D., Stulting R.D., Sugar A., Fink N.E., et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology 1994, 101:1536-1547.
9. Sonoda Y., Sano Y., Ksander B., Streilein J.W. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 1995, 36:427-434.
10. Boisgerault F., Liu Y., Anosova N., Ehrlich E., Dana M.R., Benichou G. Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation. JImmunol 2001, 167:1891-1899.
11. Yamada J., Kurimoto I., Streilein J.W. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice. Invest Ophthalmol Vis Sci 1999, 40:2614-2621.
12. Fairchild R.L., VanBuskirk A.M., Kondo T., Wakely M.E., Orosz C.G. Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts. Transplantation 1997, 63:1807-1812.
13. Fernandez E.J., Lolis E. Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 2002, 42:469-499.
14. Le Y., Zhou Y., Iribarren P., Wang J. Chemokines and chemokine receptors: their manifold roles in homeostasis and disease. Cell Mol Immunol 2004, 1:95-104.
15. Brouard S., Soulillou J.P. Pre-transplant serum level of CXCL9 as a biomarker of acute rejection and graft failure risk in kidney transplantation. Transpl Int 2010, 23:461-462.
16. Amescua G., Collings F., Sidani A., Bonfield T.L., Rodriguez J.P., Galor A., et al. Effect of CXCL-1/KC production in high risk vascularized corneal allografts on T cell recruitment and graft rejection. Transplantation 2008, 85:615-625.
17. Morita K., Miura M., Paolone D.R., Engeman T.M., Kapoor A., Remick D.G., et al. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. JImmunol 2001, 167:2979-2984.
18. Jin Y., Chauhan S.K., Saban D.R., Dana R. Role of CCR7 in facilitating direct allosensitization and regulatory T-cell function in high-risk corneal transplantation. Invest Ophthalmol Vis Sci 2010, 51:816-821.
19. Speier S., Nyqvist D., Kohler M., Caicedo A., Leibiger I.B., Berggren P.O. Noninvasive high-resolution invivo imaging of cell biology in the anterior chamber of the mouse eye. Nat Protoc 2008, 3:1278-1286.
20. Abdulreda M.H., Faleo G., Molano R.D., Lopez-Cabezas M., Molina J., Tan Y., et al. High-resolution, noninvasive longitudinal live imaging of immune responses. Proc Natl Acad Sci U S A 2011, 108:12863-12868.
21. He Y.G., Ross J., Niederkorn J.Y. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci 1991, 32:2723-2728.
22. Ayliffe W., Alam Y., Bell E.B., McLeod D., Hutchinson I.V. Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody. Br J Ophthalmol 1992, 76:602-606.
23. Hegde S., Beauregard C., Mayhew E., Niederkorn J.Y. CD4(+) T-cell-mediated mechanisms of corneal allograft rejection: role of Fas-induced apoptosis. Transplantation 2005, 79:23-31.
24. Loetscher M., Amara A., Oberlin E., Brass N., Legler D., Loetscher P., et al. TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function. Curr Biol 1997, 7:652-660.
25. Unutmaz D., Xiang W., Sunshine M.J., Campbell J., Butcher E., Littman D.R. The primate lentiviral receptor Bonzo/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse. JImmunol 2000, 165:3284-3292.
26. Latta M., Mohan K., Issekutz T.B. CXCR6 is expressed on T cells in both T helper type 1 (Th1) inflammation and allergen-induced Th2 lung inflammation but is only a weak mediator of chemotaxis. Immunology 2007, 121:555-564.
27. Inoue M., Williams K.L., Gunn M.D., Shinohara M.L. NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2012, 109:10480-10485.
28. Matloubian M., David A., Engel S., Ryan J.E., Cyster J.G. Atransmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 2000, 1:298-304.
29. Jiang X., Sun W., Zhu L., Guo D., Jiang H., Ma D., et al. Expression of CXCR6 on CD8(+) T cells was up-regulated in allograft rejection. Transpl Immunol 2010, 22:179-183.
30. Tan Y., Abdulreda M.H., Cruz-Guilloty F., Cutrufello N., Shishido A., Martinez R.E., et al. Role of T cell recruitment and chemokine-regulated intra-graft T cell motility patterns in corneal allograft rejection. Am J Transplant 2013, 13:1461-1473.
31. Baba M., Nishimura O., Kanzaki N., Okamoto M., Sawada H., Iizawa Y., et al. Asmall-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci U S A 1999, 96:5698-5703.
32. Gao P., Zhou X.Y., Yashiro-Ohtani Y., Yang Y.F., Sugimoto N., Ono S., et al. The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3. JLeukoc Biol 2003, 73:273-280.
33. Kaestel C.G., Lovato P., Odum N., Nissen M.H., Ropke C. The immune privilege of the eye: human retinal pigment epithelial cells selectively modulate T-cell activation invitro. Curr Eye Res 2005, 30:375-383.
34. Zamiri P., Masli S., Kitaichi N., Taylor A.W., Streilein J.W. Thrombospondin plays a vital role in the immune privilege of the eye. Invest Ophthalmol Vis Sci 2005, 46:908-919.
35. de Jong P.T. Age-related macular degeneration. NEngl J Med 2006, 355:1474-1485.
36. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421.
37. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
38. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
39. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber A.J., Hardisty L.I., et al. Acommon haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 2005, 102:7227-7232.
40. Gurne D.H., Tso M.O., Edward D.P., Ripps H. Antiretinal antibodies in serum of patients with age-related macular degeneration. Ophthalmology 1991, 98:602-607.
41. Patel N., Ohbayashi M., Nugent A.K., Ramchand K., Toda M., Chau K.Y., et al. Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology 2005, 115:422-430.
42. Beatty S., Koh H., Phil M., Henson D., Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000, 45:115-134.
43. Strauss O. The retinal pigment epithelium. Webvision: the organization of the retina and visual system 1995, [Salt Lake City (UT)]. H. Kolb, E. Fernandez, R. Nelson (Eds.).
44. Salomon R.G., Hong L., Hollyfield J.G. Discovery of carboxyethylpyrroles (CEPs): critical insights into AMD, autism, cancer, and wound healing from basic research on the chemistry of oxidized phospholipids. Chem Res Toxicol 2011, 24:1803-1816.
45. Schutt F., Bergmann M., Holz F.G., Kopitz J. Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin ofhuman retinal pigment epithelium. Invest Ophthalmol Vis Sci 2003, 44:3663-3668.
46. Weismann D., Hartvigsen K., Lauer N., Bennett K.L., Scholl H.P., Charbel Issa P., et al. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 2011, 478:76-81.
47. Thakkinstian A., Han P., McEvoy M., Smith W., Hoh J., Magnusson K., et al. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet 2006, 15:2784-2790.
48. Crabb J.W., Miyagi M., Gu X., Shadrach K., West K.A., Sakaguchi H., et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 2002, 99:14682-14687..
49. Hollyfield J.G., Perez V.L., Salomon R.G. Ahapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration. Mol Neurobiol 2010, 41:290-298.
50. Gu J., Pauer G.J., Yue X., Narendra U., Sturgill G.M., Bena J., et al. Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers. Mol Cell Proteomics 2009, 8:1338-1349. Clinical Genomic and Proteomic AMD Study Group.
51. Gu X., Meer S.G., Miyagi M., Rayborn M.E., Hollyfield J.G., Crabb J.W., et al. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. JBiol Chem 2003, 278:42027-42035.
52. Hollyfield J.G., Bonilha V.L., Rayborn M.E., Yang X., Shadrach K.G., Lu L., et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 2008, 14:194-198.
53. Luhmann U.F., Robbie S., Munro P.M., Barker S.E., Duran Y., Luong V., et al. The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci 2009, 50:5934-5943.
54. Cruz-Guilloty F., Saeed A.M., Echegaray J.J., Duffort S., Ballmick A., Tan Y., et al. Infiltration of proinflammatory m1 macrophages into the outer retina precedes damage in a mouse model of age-related macular degeneration. Int J Inflamm 2013, 2013. 503725.
55. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969.
56. Cao X., Shen D., Patel M.M., Tuo J., Johnson T.M., Olsen T.W., et al. Macrophage polarization in the maculae of age-related macular degeneration: a pilot study. Pathol Int 2011, 61:528-535.
57. Morohoshi K., Goodwin A.M., Ohbayashi M., Ono S.J. Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration. JAutoimmun 2009, 33:247-254.
58. Morohoshi K., Ohbayashi M., Patel N., Chong V., Bird A.C., Ono S.J. Identification of anti-retinal antibodies in patients with age-related macular degeneration. Exp Mol Pathol 2012, 93:193-199.
59. Luger D., Silver P.B., Tang J., Cua D., Chen Z., Iwakura Y., et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. JExp Med 2008, 205:799-810.
60. Gregerson D.S., Heuss N.D., Lehmann U., McPherson S.W. Peripheral induction of tolerance by retinal antigen expression. JImmunol 2009, 183:814-822.
61. Liu B., Wei L., Meyerle C., Tuo J., Sen H.N., Li Z., et al. Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. JTransl Med 2011, 9:1-12.
62. Wei L., Liu B., Tuo J., Shen D., Chen P., Li Z., et al. Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Rep 2012, 2:1151-1158.
63. Binder C.J., Hartvigsen K., Chang M.K., Miller M., Broide D., Palinski W., et al. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. JClin Invest 2004, 114:427-437.
64. Dhillon B., Wright A.F., Tufail A., Pappworth I., Hayward C., Moore I., et al. Complement factor h autoantibodies and age-related macular degeneration. Invest Ophthalmol Vis Sci 2010, 51:5858-5863.
65. Jamin C., Renaudineau Y., Pers J.O. Pierre Youinou: when intuition and determination meet autoimmunity. JAutoimmun 2012, 39:117-120.
66. Gershwin M.E., Shoenfeld Y. Chella David: a lifetime contribution in translational immunology. JAutoimmun 2011, 37:59-62.
67. Tzioufas A.G., Kapsogeorgou E.K., Moutsopoulos H.M. Pathogenesis of Sjogren's syndrome: what we know and what we should learn. JAutoimmun 2012, 39:4-8.